Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

2

Revenue 2017

Revlimid

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Revlimid was produced by Celgene.

European biotech: a new generation of leaders emerges

European biotech: a new generation of leaders emerges

The phase 2 L-MIND study in diffuse large B-cell lymphoma (DLBCL) showed the combination of tafasitamab with Celgene’s Revlimid (lenalidomide) had an overall response rate of 60%, with

Celgene boosts IO presence with Immatics deal

Celgene boosts IO presence with Immatics deal Celgene's cash cow blockbuster Revlimid is expected to face limited patent expiry in in the US from 2022, with full exposure not currently scheduled  until 2029, though it will be

GSK preps filings for BCMA-targeting multiple myeloma drug

GSK preps filings for BCMA-targeting multiple myeloma drug DREAMM-2 looked at two doses of GSK2857916 in both BCMA-positive and BCMA-negative patients who had failed earlier treatment with an immuno-modulatory drug such as Celgene’s Revlimid

BMS buoyed by FDA approval of Celgene’s myelofibrosis drug

BMS buoyed by FDA approval of Celgene’s myelofibrosis drug The approval is the latest in a string of regulatory wins for Celgene, coming after approval of a combination of Revlimid (lenalidomide) and Roche’s Rituxan (rituximab) – known as the R2

Triplet approvals for myeloma boost Celgene in Q2

Triplet approvals for myeloma boost Celgene in Q2 Surge in approvals and pipeline as merger nears. Celgene has reported higher-than-expected second-quarter revenues on the back of new triple therapy approvals for myeloma blockbusters Revlimid and Pomalyst. ... Sales came in at $4.40bn, with Revlimid

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics